Fidelity Investments’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-87,667
| Closed | -$428K | – | 5335 |
|
|
2025
Q1 | $428K | Buy |
87,667
+40,039
| +84% | +$241K | ﹤0.01% | 2954 |
|
|
2024
Q4 | $397K | Sell |
47,628
-76,470
| -62% | -$668K | ﹤0.01% | 3015 |
|
|
2024
Q3 | $1.29M | Buy |
124,098
+9,345
| +8% | +$155K | ﹤0.01% | 2528 |
|
|
2024
Q2 | $2.26M | Sell |
114,753
-4,278
| -4% | -$85.7K | ﹤0.01% | 2319 |
|
|
2024
Q1 | $3.05M | Buy |
119,031
+203
| +0.2% | +$5.2K | ﹤0.01% | 2208 |
|
|
2023
Q4 | $3.28M | Buy |
118,828
+110,567
| +1,338% | +$6.74M | ﹤0.01% | 2188 |
|
|
2023
Q3 | $502K | Buy |
8,261
+554
| +7% | +$38.9K | ﹤0.01% | 2632 |
|
|
2023
Q2 | $507K | Buy |
7,707
+2,252
| +41% | +$165K | ﹤0.01% | 2656 |
|
|
2023
Q1 | $347K | Buy |
5,455
+21
| +0.4% | +$2.4K | ﹤0.01% | 2814 |
|
|
2022
Q4 | $752K | Sell |
5,434
-77
| -1% | -$10.8K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $698K | Buy |
5,511
+155
| +3% | +$17.5K | ﹤0.01% | 2686 |
|
|
2022
Q2 | $443K | Buy |
5,356
+68
| +1% | +$5.27K | ﹤0.01% | 2886 |
|
|
2022
Q1 | $513K | Buy |
5,288
+5,287
| +528,700% | +$698K | ﹤0.01% | 2983 |
|
|
2021
Q4 | $0 | Sell |
1
-1
| -50% | -$236 | ﹤0.01% | 4349 |
|
|
2021
Q3 | $1K | Sell |
2
-960
| -100% | -$274K | ﹤0.01% | 4098 |
|
|
2021
Q2 | $399K | Sell |
962
-18
| -2% | -$7.13K | ﹤0.01% | 2813 |
|
|
2021
Q1 | $382K | Sell |
980
-1,875
| -66% | -$923K | ﹤0.01% | 2726 |
|
|
2020
Q4 | $1.6M | Sell |
2,855
-583
| -17% | -$369K | ﹤0.01% | 2445 |
|
|
2020
Q3 | $2.4M | Sell |
3,438
-60,123
| -95% | -$46.9M | ﹤0.01% | 2263 |
|
|
2020
Q2 | $50.3M | Sell |
63,561
-220,512
| -78% | -$166M | 0.01% | 1159 |
|
|
2020
Q1 | $169M | Sell |
284,073
-188,502
| -40% | -$184M | 0.02% | 559 |
|
|
2019
Q4 | $537M | Sell |
472,575
-130,514
| -22% | -$142M | 0.06% | 300 |
|
|
2019
Q3 | $717M | Sell |
603,089
-35,238
| -6% | -$53.8M | 0.09% | 228 |
|
|
2019
Q2 | $1.05B | Buy |
638,327
+1,992
| +0.3% | +$3.45M | 0.12% | 161 |
|
|
2019
Q1 | $1.3B | Buy |
636,335
+2,974
| +0.5% | +$5.24M | 0.16% | 126 |
|
|
2018
Q4 | $814M | Buy |
633,361
+6,212
| +1% | +$9.53M | 0.11% | 161 |
|
|
2018
Q3 | $1.19B | Buy |
627,149
+46,768
| +8% | +$96.6M | 0.13% | 147 |
|
|
2018
Q2 | $1.18B | Buy |
580,381
+1,572
| +0.3% | +$3.58M | 0.14% | 144 |
|
|
2018
Q1 | $1.28B | Buy |
578,809
+10,530
| +2% | +$26.8M | 0.15% | 136 |
|
|
2017
Q4 | $1.31B | Buy |
568,279
+40,354
| +8% | +$81.9M | 0.15% | 134 |
|
|
2017
Q3 | $939M | Buy |
527,925
+9,608
| +2% | +$13.4M | 0.11% | 186 |
|
|
2017
Q2 | $705M | Buy |
518,317
+45,335
| +10% | +$54.7M | 0.09% | 246 |
|
|
2017
Q1 | $557M | Buy |
472,982
+2,913
| +0.6% | +$2.97M | 0.07% | 291 |
|
|
2016
Q4 | $376M | Buy |
470,069
+39,641
| +9% | +$31.5M | 0.05% | 409 |
|
|
2016
Q3 | $378M | Buy |
430,428
+2,628
| +0.6% | +$1.9M | 0.05% | 407 |
|
|
2016
Q2 | $240M | Buy |
427,800
+178
| +0% | +$101K | 0.03% | 585 |
|
|
2016
Q1 | $235M | Buy |
427,622
+2,903
| +0.7% | +$1.78M | 0.03% | 578 |
|
|
2015
Q4 | $353M | Buy |
424,719
+4,786
| +1% | +$4.78M | 0.05% | 422 |
|
|
2015
Q3 | $465M | Buy |
419,933
+5,709
| +1% | +$10.4M | 0.07% | 324 |
|
|
2015
Q2 | $903M | Buy |
414,224
+49,857
| +14% | +$102M | 0.12% | 182 |
|
|
2015
Q1 | $570M | Sell |
364,367
-85
| -0% | -$112K | 0.07% | 311 |
|
|
2014
Q4 | $433M | Buy |
364,452
+33,629
| +10% | +$22.5M | 0.06% | 377 |
|
|
2014
Q3 | $154M | Buy |
330,823
+47,160
| +17% | +$21.8M | 0.02% | 771 |
|
|
2014
Q2 | $142M | Buy |
283,663
+3,861
| +1% | +$1.24M | 0.02% | 815 |
|
|
2014
Q1 | $82.4M | Buy |
279,802
+4,612
| +2% | +$1.4M | 0.01% | 1084 |
|
|
2013
Q4 | $74.8M | Buy |
275,190
+154,209
| +127% | +$43.1M | 0.01% | 1115 |
|
|
2013
Q3 | $42.2M | Buy |
+120,981
| New | +$44.9M | 0.01% | 1370 |
|
Other funds holding BLUE
Fidelity Investments's BLUE Position: Q2 2025 in Review
Fidelity Investments sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 87,667 shares — an estimated $428K sold.
Fidelity Investments first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $1.31B in Q4 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Fidelity Investments reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Fidelity Investments sold 87,667 bluebird bio shares in Q2 2025, an estimated $428K.
- Fidelity Investments first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Fidelity Investments's bluebird bio position peaked at $1.31B in Q4 2017.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.